Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duloxetine for Pain in Parkinson's Disease
NCT01504178Phase 3Completed
- Sponsor
- Centre hospitalier universitaire de Toulouse
- Start
- May 2011
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of duloxetine in Parkinson's disease (PD), sponsored by Centre hospitalier universitaire de Toulouse. Started May 2011; status: completed.
02
Drugs
duloxetine
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT01504178.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01504178.